The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PANOVA-3: A phase 3 study of tumor treating fields (TTFields) with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic adenocarcinoma.
 
Vincent J. Picozzi
Stock and Other Ownership Interests - Amgen; Cigna; Johnson & Johnson; McKesson; Thermo Fisher Scientific
Consulting or Advisory Role - TriSalus Life Sciences
Research Funding - Abbvie; Celgene; FibroGen; Ipsen; Merck; NGM Biopharmaceuticals; NovoCure; Tyme
 
Teresa Macarulla
Consulting or Advisory Role - Ability Pharma; Advance Medical; Aptitude Health; AstraZeneca; Basilea; Baxter; BioLineRX; Celgene; Eisai; Genzyme; Incyte; Ipsen; Lilly; Medscape; Menarini; MSD; Novocure; Paraxel; PPD; Prime Oncology; QED Therapeutics; Roche; Sanofi/Aventis; SERVIER; Swedish Orphan Biovitrum; Zymeworks
Research Funding - Agios (Inst); ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Genentech (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Merrimack (Inst); Millennium (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; H3 Biomedicine; Incyte; Merck; Prime Oncology; Sanofi; SERVIER
 
Philip A. Philip
No Relationships to Disclose
 
Carlos Roberto Becerra
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - Agenus; Bayer; HERON; Ipsen; SOBI; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Taiho Pharmaceutical
 
Tomislav Dragovich
Research Funding - ARMO BioSciences; Berg Pharma; Bristol-Myers Squibb (Inst); Halozyme (Inst); HolyStone Therapeutics (Inst); Kyowa Hakko Kirin; Medivir; Novocure (Inst); Rgenix